The generic labeling rule that had been drafted by the US FDA may not wind up implemented in its current form under a Scott Gottlieb-run agency, but the issue likely will not disappear.
Gottlieb opposes the proposed rule that would allow generic firms to change their labels without prior authorization. But in response...






